gMendel® announces new Head of Product

We are happy to announce Dr. Robert Burger as our Head of Product. Our planned growth for the upcoming years is exciting and full of opportunities. As a part of this forward thinking, we believe that with Robert on board, we can focus on developing products that match our customers’ needs for early detection of rare diseases and therefore contribute to reproductive autonomy and better disease management.

“We are very happy to welcome Robert to the gMendel team! Robert’s vast experience in the diagnostics industry, not least as the co-founder of Blusense Diagnostics, will be instrumental in accelerating gMendel’s product development activities”, said Chris Kyriakidis, CEO and co-founder of gMendel.

Robert has always been driven by one goal – to turn science into products that help improve people’s life. He has deep knowledge of the medtech industry and IVD products, as well as a broad scientific and business background.

“I am excited to support the gMendel team in their journey to bring to market their rapid, accurate and low cost technology for detecting genetic disorders. Early diagnosis allows to start disease management as soon as possible and improve the lives of those affected. Combining DNA sequencing with artificial intelligence has the potential to dramatically improve the diagnosis of genetic disorders. I am impressed by the knowledge and commitment of the whole team and by what Zoran and Chris have built in just 2 years since founding the company”, said Robert Burger.